Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
- DOI
- 10.1186/s12885-019-6177-0
- Published
- 2019 Oct 17
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-019-6177-0,
title = {Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.},
author = {Brito C and Azevedo A and Esteves S and Marques AR and Martins C and Costa I and Mafra M and Bravo Marques JM and Roque L and Pojo M},
year = {2019},
journal = {BMC cancer},
doi = {10.1186/s12885-019-6177-0},
url = {https://doi.org/10.1186/s12885-019-6177-0}
}RIS
TY - JOUR TI - Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. AU - Brito C AU - Azevedo A AU - Esteves S AU - Marques AR AU - Martins C AU - Costa I AU - Mafra M AU - Bravo Marques JM AU - Roque L AU - Pojo M PY - 2019 JO - BMC cancer DO - 10.1186/s12885-019-6177-0 UR - https://doi.org/10.1186/s12885-019-6177-0 ER -
APA
C, B., A, A., S, E., AR, M., C, M., I, C., M, M., JM, B. M., L, R., & M, P. (2019). Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.. BMC cancer. https://doi.org/10.1186/s12885-019-6177-0
Source records
- pubmed · retrieved 2026-09-26T02:33:46.285Z